Yucai Peng
Zhuhai, 519000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
An optimized intranasal LNP formulation for potent immune responses of mRNA-based RSV vaccines.
Journal: Nanoscale
Published: October 10, 2025
Herpes zoster mRNA vaccine elicits superior immune responses over licensed vaccines with a favorable safety profile in animal models.
Journal: Vaccine
Published: May 12, 2025
An mRNA-Based Respiratory Syncytial Virus Vaccine Elicits Strong Neutralizing Antibody Responses and Protects Rodents Without Vaccine-Associated Enhanced Respiratory Disease.
Journal: Vaccines
Published: November 23, 2024
Local administration of mRNA encoding cytokine cocktail confers potent anti-tumor immunity.
Journal: Frontiers in immunology
Published: June 26, 2024
A full-length glycoprotein mRNA vaccine confers complete protection against severe fever with thrombocytopenia syndrome virus, with broad-spectrum protective effects against bandaviruses.
Journal: Journal of virology
Published: June 03, 2024
Efficacy, safety, and immunogenicity of SARS-CoV-2 mRNA vaccine (Omicron BA.5) LVRNA012: a randomized, double-blind, placebo-controlled phase 3 trial.
Journal: Frontiers in immunology
Published: April 07, 2024
Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques.
Journal: NPJ vaccines
Published: March 06, 2024
Evaluating the Metabolic Basis of α-Gal A mRNA Therapy for Fabry Disease.
Journal: Biology
Published: December 21, 2023
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.
Journal: Vaccine
Published: July 06, 2023
Development of Bivalent mRNA Vaccines against SARS-CoV-2 Variants.
Journal: Vaccines
Published: September 13, 2022
An mRNA-based rabies vaccine induces strong protective immune responses in mice and dogs.
Journal: Virology journal
Published: April 13, 2022
Last Updated: 09/26/2026